GlassScriptPhysician profile
Joey Liu
NPI 1538137013
$239.91
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.37 · 2020: $15.03 · 2021: $27.78 · 2022: $107.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $106.73 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $27.78 | 2021 | |
| Sanofi Pasteur INC. | $24.22 | 2019 | |
| Vertiflex, INC. | $17.82 | 2019 | |
| Electronic Waveform Lab, INC. | $16.93 | 2019 | |
| Melinta Therapeutics, LLC | $16.80 | 2019 | |
| Nabriva Therapeutics, Plc | $15.03 | 2020 | |
| Boston Scientific Corporation | $14.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.